clinical case discussion - iweventos [2] ricardo... · ricardo carvalho oncologista clínico...
TRANSCRIPT
![Page 1: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/1.jpg)
Ricardo CarvalhoOncologista Clínico
Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo
09 de Agosto de 2019
Clinical case discussion
![Page 2: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/2.jpg)
NCO, 51 y/o. Male. Without co-morbidities
Hematochezia (no signals of intestinal obstruction)
12/Dec/18 Colonoscopy: infiltrative lesion in the retossigmoid
occupying 30% of organ lumen. No difficulty to overpass the lesion with
the device
- AP: Adenocarcinoma (tubular) grade 2.
RAS status unknow
22/Dec/18 CEA 413
![Page 3: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/3.jpg)
22/Dec/18 Abdome MRI:
![Page 4: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/4.jpg)
22/Dec/18 Abdome MRI:
![Page 5: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/5.jpg)
22/Dec/18 Abdome MRI:
![Page 6: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/6.jpg)
22/Dec/18 Abdome MRI:
![Page 7: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/7.jpg)
22/Dec/18 Abdome MRI:
![Page 8: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/8.jpg)
22/Dec/18 Abdome MRI:
- infiltrative lesion in the retossigmoid, above the peritoneal reflection,
with extramural extension.
- lymph nodes enlargement (~15 mm).
- multiple bilateral hepatic lesions:
- segment VII/VIII (68 mm)
- segment IVa/VIII (62 mm)
- segment V (46 mm e 42 mm)
- segment VI (32 mm)
![Page 9: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/9.jpg)
Would you approach the primary tumor at this time?
1. Yes
2. No
![Page 10: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/10.jpg)
How would you rate this liver colorectal metastatic disease?
1. Unresectable
2. Borderline resectable
![Page 11: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/11.jpg)
What would be your choice?
1. Doublet
2. Doublet + Bevacizumab
3. Triplet
4. Triplet + Bevacizumab
![Page 12: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/12.jpg)
12/Jan/19 Started FOLFOXIRI + Bevacizumab q2w 1 cycle
Pain resolution
all-RAS and BRAF wt
![Page 13: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/13.jpg)
What would be your choice at this time?
1. Maintain FOLFOXIRI + Bevacizumab
2. FOLFIRI + Cetuximab
3. FOLFOX + Cetuximab
4. FOLFOX + Panitumumab
![Page 14: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/14.jpg)
What would be your choice at this time?
1. Maintain FOLFOXIRI + Bevacizumab
2. FOLFIRI + Cetuximab
3. FOLFOX + Cetuximab
4. FOLFOX + Panitumumab
![Page 15: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/15.jpg)
12/Jan/19 to 05/Jun/19 FOLFOXIRI + Bevacizumab q2w 7 cycles
05/Jun/19 FOLFOXIRI (without bevacizumab)
CEA 48 (before 413)
![Page 16: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/16.jpg)
20/Jun/19 Abdome MRI:
![Page 17: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/17.jpg)
20/Jun/19 Abdome MRI:
![Page 18: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/18.jpg)
20/Jun/19 Abdome MRI:
![Page 19: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/19.jpg)
20/Jun/19 Abdome MRI:
![Page 20: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/20.jpg)
20/Jun/19 Abdome MRI:
![Page 21: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/21.jpg)
What would be your choice?
1. Resection of the hepatic lesions and the primary tumor at the
same time
2. Resection of the hepatic lesions at the same time
3. Resection of the hepatic lesions (in two different times)
4. Primary tumor surgery hepatic lesions
5. Maintain palliative chemotherapy
![Page 22: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/22.jpg)
What would be your choice?
1. Resection of the hepatic lesions and the primary tumor at the
same time
2. Resection of the hepatic lesions at the same time
3. Resection of the hepatic lesions (in two different times)
4. Primary tumor surgery hepatic lesions
5. Maintain palliative chemotherapy
![Page 23: Clinical case discussion - IWEVENTOS [2] Ricardo... · Ricardo Carvalho Oncologista Clínico Hospitais BP Mirante e BP da Beneficência Portuguesa de São Paulo 09 de Agosto de 2019](https://reader034.vdocument.in/reader034/viewer/2022042022/5e792e874857f572b86c8ae3/html5/thumbnails/23.jpg)
17/Jul/19 Resection of the hepatic lesions in the segments II and
III and of the isolated nodule (10mm) in the segment I
02/Aug/19 Embolization of the right portal vein and of the
segments IVA e IVB
Next step: right hepatectomy